Catalyst Wire Dossier Catalyst Wire Dossier

Lymfactin

· Herantis Pharma Plc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lymfactin, covering 2025-07-09 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE) [Phase 2]

See pricing